A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding

Background and Study Aims. The optimal dose of intravenous proton-pump inhibitor (PPI) therapy for the prevention of peptic ulcer (PU) rebleeding remains controversial. This study aimed to understand the real world experiences in prescribing high-dose PPI and non-high-dose PPI for preventing rebleed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lu, Lung-Sheng, Lin, Sheng-Chieh, Kuo, Chung-Mou, Tai, Wei-Chen, Tseng, Po-Lin, Chang, Kuo-Chin, Kuo, Chung-Huang, Chuah, Seng-Kee
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403596/
https://ncbi.nlm.nih.gov/pubmed/22844276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/858612
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados